Please select the option that best describes you:

Can a patient s/p EBRT for intermediate risk prostate cancer who is clinically and biochemically free of disease safely receive supplemental testosterone therapy?  

The serum testosterone is minimally low at 250 and the patient has some fatigue.



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Christus St Vincent
Is there a 2023 update for testosterone replacemen...
Sign in or Register to read more